The RejuvenAir® System has been designated as a Breakthrough Device by the U.S. FDA. The company has also received unconditional IDE approval to initiate a pivotal clinical study.
Medtronic says Microstream™ Capnography study shows a greater than 40% incidence of opioid induced respiratory compromise
RejuvenAir® feasibility study demonstrate strong safety profile and clinically meaningful improvement on Quality of Life measures at 6-month follow-up in Chronic Bronchitis patients.
Studies presented at the European Society of Thoracic Surgeons meeting examine the impact of innovation on both patient outcomes and hospital costs
Evidence-based guidelines based on a large-scale sleep apnea study demonstrate WatchPAT’s efficiency and accuracy
System safe, accurate and effective in bronchoscopically navigating and accessing tumors anywhere in the lung
All primary and secondary endpoints met across multiple measures of breathing and quality of life, one year after treatment
Real-world assessment favours powered staplers over manual, with halved rate of hemostasis complications
Already available around the world, Pulmonx hopes to get FDA nod for U.S. patients
Leading UK pulmonologist interprets new guidance to mean that all eligible patients should be referred to specialists for consideration for endobronchial valve treatment.
Portable analyzer helps patients manage their asthma by measuring nitric oxide (NO) in their exhaled breath, a biomarker foreshadowing airway obstruction
Significant improvements in breathing, mobility and quality of life for emphysema patients
Adherium’s SmartTurbo Model 4 is dedicated to AstraZeneca’s Turbuhaler
Irish device company, Novate Medical sees compelling results presented at VIVA 2017
Point-of-care portable breath analyzer measures patients’ nitric oxide in exhaled breath, a predictive biomarker for airway obstruction
Data show improved adherence by up to 59% in adults and 180% in children